SPDE Speedus Corp (CE)

PRINCETON, N.J., Oct. 26 /PRNewswire/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE) and developer of computer-aided medical devices, today announced that its portfolio of intellectual property has been broadened following the issuance of a fundamental new patent. The patent-number 6,953,436-was issued on October 11, 2005. The patent is entitled "Multi-modal cardiac diagnostic decision support system and method", and expands Zargis' extensive portfolio of protected technologies by describing a method of extracting and evaluating features from cardiac acoustic signals and a means for determining whether or not the sounds are innocent or indicative of disease based on expert rules. Among other things, the inventions covered by this patent could aid a physician in detecting valvular heart diseases that might otherwise go undiagnosed, discriminating pathological from innocent heart murmurs and making better patient referral decisions while documenting the basis for the decision. "Ingenuity and creativity are cornerstones of the Zargis organization and culture. We continue to make significant investments in the enhancement of our diagnostic algorithms and the expansion of our patent portfolio with the firm belief that our computer-aided auscultation technology will become a new standard in healthcare," commented John Kallassy, Zargis' CEO. Zargis currently controls 12 patents and patent applications. About Zargis Medical Corp. Zargis Medical Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds. About Speedus Corp. Speedus Corp. is a holding company with controlling interests in Zargis Medical Corp. and F&B Gudtfood Holdings, Inc. Speedus Corp. also owns broadband intellectual property and controls licensed wireless frequencies. For additional information about Zargis Medical or Speedus Corp., visit the following Web sites: http://www.zargis.com/ and http://www.speedus.com/. Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward- looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts. DATASOURCE: Zargis Medical Corp. CONTACT: Peter Hodge, +1-203-829-1348, , for Zargis Medical Corp. Web site: http://www.speedus.com/ http://www.zargis.com/

Copyright